Kei Ishizuchi
Keio, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Late-onset Human Herpesvirus 6 Encephalitis with Secondary Hemophagocytic Lymphohistiocytosis after CAR T-cell Therapy.
Journal: Internal medicine (Tokyo, Japan)
Published: August 19, 2026
Reply: Intention-to-treat analysis, MOH remission, and mechanistic insights: Reframing the 12-month CGRP mAb experience.
Journal: Journal of the neurological sciences
Published: April 14, 2026
Author's reply: Bickerstaff Brainstem Encephalitis with Decorticate-like Posture, Involuntary Movements, Impaired Visual Acuity, and Prolonged Motor Disability.
Journal: Internal medicine (Tokyo, Japan)
Published: March 26, 2026
Reply: Pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: A comment on Imai et al.
Journal: Journal of the neurological sciences
Published: February 03, 2026
Bickerstaff Brainstem Encephalitis with a Decorticate-like Posture, Involuntary Movements, Impaired Visual Acuity, and Prolonged Motor Disability.
Journal: Internal medicine (Tokyo, Japan)
Published: January 14, 2026
Early Recovery from Cryptogenic NORSE Following Repeated C-NORSE Score Assessment and Cyclophosphamide Treatment.
Journal: Internal medicine (Tokyo, Japan)
Published: October 22, 2025
A 12-month observational study on the safety, efficacy on migraine-associated symptoms and satisfaction of CGRP monoclonal antibodies in Japanese patients with migraine.
Journal: Journal of the neurological sciences
Published: September 26, 2025
Effect of Galcanezumab on PHQ-9 and GAD-7 in Patients with Migraine: A Real-world Study in Japan.
Journal: Internal medicine (Tokyo, Japan)
Published: August 13, 2025
Efficacy and Safety of Switching between Anti-CGRP Monoclonal Antibodies: A Detailed Monthly and Long-term Follow-up Study and Literature Review.
Journal: Internal medicine (Tokyo, Japan)
Published: January 05, 2025
Real-world Efficacy of Erenumab on Migraine-associated Symptoms and Patient-reported Satisfaction Levels: A Retrospective Study in Japan.
Journal: Internal medicine (Tokyo, Japan)
Published: August 07, 2024
Efficacy and tolerability of 100 mg of lasmiditan for migraine: A multi-center, prospective observational real-world study in Japan.
Journal: Cephalalgia : an international journal of headache
Published: June 11, 2024
Worsening of myasthenic symptoms associated with statins.
Journal: Journal of the neurological sciences
Published: February 23, 2024
Last Updated: 09/26/2026